Regenerex Pharma (RGPX) Current Leases (2023 - 2025)
Regenerex Pharma (RGPX) reported Current Leases of $191181.0 for Q3 2025, up 14.96% year-over-year from $166308.0 in Q3 2024, and up 14.02% on a QoQ basis from $167673.0 in Q2 2025.
Regenerex Pharma (RGPX) has 3 years of Current Leases data on file, last reported at $191181.0 in Q3 2025.
- Quarterly Current Leases rose 14.96% year-over-year to $191181.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $191181.0 (up 14.96% YoY) and the FY2025 annual result came in at $181894.0, up 41.81% from the prior year.
- Current Leases grew to $191181.0 in Q3 2025 per RGPX's latest filing, from $167673.0 in the prior quarter.
- Across five years, Current Leases topped out at $191181.0 in Q3 2025 and bottomed at $128264.0 in Q1 2024.
- The 3-year median for Current Leases is $166990.5 (2024), against an average of $163822.5.
- Peak annual rise in Current Leases reached 41.81% in 2025, while the deepest fall reached 3.78% in 2025.
- Tracing RGPX's Current Leases over 3 years: stood at $152046.0 in 2023, then gained by 16.69% to $177422.0 in 2024, then advanced by 7.75% to $191181.0 in 2025.
- Per Business Quant, the three latest RGPX Current Leases figures stand at $191181.0 (Q3 2025), $167673.0 (Q2 2025), and $181894.0 (Q1 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 191,181.00 |
| Jun 30, 2025 | 167,673.00 |
| Mar 31, 2025 | 181,894.00 |
| Dec 31, 2024 | 177,422.00 |
| Sep 30, 2024 | 166,308.00 |
| Jun 30, 2024 | 174,259.00 |
| Mar 31, 2024 | 128,264.00 |
| Dec 31, 2023 | 152,046.00 |
| Sep 30, 2023 | 162,295.00 |
| Jun 30, 2023 | 136,883.00 |